Guideline for the Management of Chronic Obstructive Pulmonary Disease (COPD): 2004 revision

South African Medical Journal

Volumn 94, Issue 7 II, 2004, Pages 559-575

  Bateman, E D ^a,b   Feldman, C ^a   O'Brien, J ^a   Plit, M ^a   Joubert, J R ^a   Ainslie, G M ^a   Abdool Gaffar, S ^a   Bollinger, C ^a   Foden, A ^a   Greenblatt, M ^a   Irusen, E ^a   Killian, J ^a   Lalloo, U ^a   Mpe, J ^a   Mzileni, O ^a   Otto, W ^a   Pansegrouw, D ^a   Raine, R I ^a   Richards, G ^a   Visser, S ^a  

^a South African Thoracic Society   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; BUSPIRONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIGARETTE SMOKE; CIMETIDINE; CIPROFLOXACIN; CLONIDINE; CORTICOSTEROID; FENOTEROL; FORMOTEROL; IPRATROPIUM BROMIDE; MACROLIDE; METHYLPREDNISOLONE; MUCOLYTIC AGENT; NICOTINE; NORTRIPTYLINE; OXYGEN; PHENYTOIN; PREDNISONE; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE; TIOTROPIUM BROMIDE; UNINDEXED DRUG; GLUCOCORTICOID;

AIR POLLUTION; ANOREXIA; ARTICLE; AVIATION; AWARENESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEFECATION DISORDER; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED MEDICINE; FUNCTIONAL DISEASE; GASTROINTESTINAL SYMPTOM; HEALTH CARE ORGANIZATION; HEALTH PRACTITIONER; HEALTH STATUS; HEART ARRHYTHMIA; HEART PALPITATION; HOSPITAL DEPARTMENT; HUMAN; HYPOXEMIA; LONG TERM CARE; LUNG INFECTION; LUNG SURGERY; LUNG TUBERCULOSIS; LUNG VOLUME; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL SPECIALIST; MUSCLE WEAKNESS; NAUSEA; OCCUPATIONAL EXPOSURE; OSTEOPOROSIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY PREVENTION; PRIVATE PRACTICE; PROGNOSIS; PULMONOLOGY; QUALITY OF LIFE; SECONDARY PREVENTION; SMOKING CESSATION; SOUTH AFRICA; SPINE DISEASE; SPIROMETRY; SYMPTOMATOLOGY; TACHYCARDIA; TACHYPHYLAXIS; TOBACCO DEPENDENCE; TREATMENT PLANNING; TREMOR; UNIVERSITY HOSPITAL; XEROSTOMIA; DISEASE COURSE; METERED DOSE INHALER; PATHOPHYSIOLOGY; TRAVEL;

BRONCHODILATOR AGENTS; DISEASE PROGRESSION; GLUCOCORTICOIDS; HUMANS; METERED DOSE INHALERS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SPIROMETRY; TRAVEL;

EID: 4043118399     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. O'Brien J, Feldman C, Bateman ED, Plit M. Guidelines for the management of chronic obstructive pulmonary disease. For a Working Group of the South African Pulmonology Society. S Afr Med J 1998; 88: 999-1010.
2. Global Obstructive Lung Disease initiative (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHI publication no.2701, Bethesda Md: National Institutes of Health, 2001.
3. South African Demographic and Health Survey 1998: Full Report. Medical Research Council of South Africa, Department of Health, 2002.
4. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 2000; 55: 32-38.
5. Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD? - Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97: 115-122.
6. Anthonissen NR. Prognosis in chronic obstructive pulmonary disease. Results from multi-center clinical trials. Am Rev Respir Dis 1989; 140: 595-599.
7. Roberts CM, Lowe D, Bucknall CE, et al. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002; 57: 137-141.
8. Van Schalkwyk EM, Schultz C, Joubert JR, White NW. Guide for office spirometry in adults. S Afr Med J 2004; 94:
9. Quanjar PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows: report of the working party standardization of lung function tests. European Respiratory Society. Eur Respir J 1993; 6: suppl. 16, 5-40.
10. Schols AM, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-1797.
11. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airflow obstruction in patients with COPD. Chest 2002; 121: 1434-1440.
12. Anthonisen NR, Connett, Murray RP. Smoking and lung function of lung health participants after 11 years. Am J Respir Crit Care Med 2002; 166: 675-679.
13. Raw M, McNeill A, West R. Smoking cessation guidelines for health professionals. Thorax 1998: 53; (suppl. 5), S1-S19.